This Common Anti-Nausea Pill Could Be a Game-Changer for Hard-To-Treat Breast Cancers

An anti-nausea drug may reduce recurrence and death in aggressive breast cancer. Scientists are exploring its broader use in oncology. A recent study has identified a link between a widely used anti-nausea drug and improved outcomes for women with early-stage breast cancer, with especially notable effects in those with triple negative breast cancer. Researchers from […]

Source link